Business Wire

CIRIUM

23.11.2022 09:01:59 CET | Business Wire | Press release

Share
Cirium Launches First Phase of Satellite-Based Aircraft Maintenance Tracking

Cirium has revealed today the aviation industry’s first satellite-based aircraft maintenance tracking feature in its Ascend Profiles module.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221123005132/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Cirium's new Ground Events feature shows how Air France redesigned the cabins of all 15 of its Airbus A330 fleet. (Photo: Business Wire)

Its new Ground Events feature enables aircraft and engine manufacturers, maintenance, repair and overhaul service providers, parts suppliers, lessors and insurers to monitor and predict future aircraft maintenance events.

This means businesses can better understand when and where an aircraft last had a maintenance event and forecast its next visit.

It also helps to identify aircraft transitions and define strategies around how and where maintenance and aftermarket budgets are being allocated by operators or owners.

Jeremy Bowen, CEO at Cirium said: “We are innovators and constantly looking to surface new ideas to empower the aviation industry.

“By tracking each Ground Event of an airline’s aircraft, we can identify whether it was for redesigned cabins, new aircraft branding, a maintenance event, or for its return to service.”

The first phase of the new Ground Events feature captures all instances when aircraft spend over seven days on the ground and identifies the aircraft registration, airport, arrival date and time, departure date and time, ground event duration (in days) and aircraft age. For specific airlines the feature showcases the types of maintenance activity and the provider.

The new feature demonstrates the power of combining Cirium’s unrivaled fleets and advanced satellite-based flight tracking data with the MRO locations and MRO relationships data.

In one example, it shows Air France has been redesigning the cabin interiors of all 15 of their Airbus A330 fleet to match the interiors of their A350 aircraft.

This reflects the carrier’s focus on enhancing the passenger experience and benefitted the airline when air travel started to return post the COVID-19 lockdowns. All 15 A330s were ready to return to service with the new interiors installed in July 2020.

Meanwhile, the feature shows how Lufthansa returned five of their Airbus A340s, which were due for retirement, back into service as the pandemic impacted the deliveries of new aircraft.

It further records how the airline partnered with IAC in Dublin to repaint the A340s in the new Lufthansa livery and regular maintenance checks were conducted by Lufthansa Technik Malta, Lufthansa Technik Philippines, and Joramco.

Given the increased demand during the pandemic for the shipment of PPE and the rise of ecommerce, Cirium’s Ground Events data shows how Federal Express (FedEx) were able to maximize their fleet and leverage strong relationships with their maintenance provider. FedEx ramped up their cargo flights, utilizing young aircraft – around one-to-eight years old – and maintained a consistent two-year maintenance cycle.

The Ground Events feature is part of the Ascend Profiles User Interface (UI) which visualizes aircraft intelligence of airline and lessor profiles and provides quick insights around aircraft types, airport locations, OEMs, MROs and more. The is available as an app and works across desktop, mobile and tablet. Find out more.

About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

For further information please follow Cirium updates on LinkedIn or Twitter or visit www.cirium.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221123005132/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bial Announces Completion of Phase 2b ACTIVATE Study with BIA 28-6156 in GBA1-Associated Parkinson’s26.5.2026 08:00:00 CEST | Press release

Study Topline results will be released around the end of Q2 2026 BIA 28-6156 is being developed as a potential first-in-class disease-modifying therapy in GBA-PD Bial was present at the GBA1 conference and is currently attending the World Parkinson Congress Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced the completion of the treatment period in its Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who have a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene (GBA-PD). Upon completion of the 78-week double-blind treatment period and all scheduled safety follow-ups, data cleaning and analysis are currently ongoing. Topline results will be released around the end of Q2. A status report on the ACTIVATE study was presented in an oral presentation at the 3rd International GBA1 Meeting 2026. The team is currently attending the 7th World Parkinson Congress, taking place in Pho

Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release

Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye